SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment.

Bruni, C; Buch, MH; Djokovic, A; De Luca, G; Dumitru, RB; Giollo, A; Galetti, I; Steelandt, A; Bratis, K; Suliman, YA; et al. Bruni, C; Buch, MH; Djokovic, A; De Luca, G; Dumitru, RB; Giollo, A; Galetti, I; Steelandt, A; Bratis, K; Suliman, YA; Milinkovic, I; Baritussio, A; Hasan, G; Xintarakou, A; Isomura, Y; Markousis-Mavrogenis, G; Mavrogeni, S; Gargani, L; Caforio, AL; Tschöpe, C; Ristic, A; Plein, S; Behr, E; Allanore, Y; Kuwana, M; Denton, CP; Furst, DE; Khanna, D; Krieg, T; Marcolongo, R; Pepe, A; Distler, O; Sfikakis, P; Seferovic, P; Matucci-Cerinic, M (2023) Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment. J Scleroderma Relat Disord, 8 (3). pp. 169-182. ISSN 2397-1991 https://doi.org/10.1177/23971983231163413
SGUL Authors: Behr, Elijah Raphael

[img] Microsoft Word (.doc) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (180kB)

Abstract

INTRODUCTION: Heart involvement is a common problem in systemic sclerosis. Recently, a definition of systemic sclerosis primary heart involvement had been proposed. Our aim was to establish consensus guidance on the screening, diagnosis and follow-up of systemic sclerosis primary heart involvement patients. METHODS: A systematic literature review was performed to investigate the tests used to evaluate heart involvement in systemic sclerosis. The extracted data were categorized into relevant domains (conventional radiology, electrocardiography, echocardiography, cardiac magnetic resonance imaging, laboratory, and others) and presented to experts and one patient research partner, who discussed the data and added their opinion. This led to the formulation of overarching principles and guidance statements, then reviewed and voted on for agreement. Consensus was attained when the mean agreement was ⩾7/10 and of ⩾70% of voters. RESULTS: Among 2650 publications, 168 met eligibility criteria; the data extracted were discussed over three meetings. Seven overarching principles and 10 guidance points were created, revised and voted on. The consensus highlighted the importance of patient counseling, differential diagnosis and multidisciplinary team management, as well as defining screening and diagnostic approaches. The initial core evaluation should integrate history, physical examination, rest electrocardiography, trans-thoracic echocardiography and standard serum cardiac biomarkers. Further investigations should be individually tailored and decided through a multidisciplinary management. The overall mean agreement was 9.1/10, with mean 93% of experts voting above 7/10. CONCLUSION: This consensus-based guidance on screening, diagnosis and follow-up of systemic sclerosis primary heart involvement provides a foundation for standard of care and future feasibility studies that are ongoing to support its application in clinical practice.

Item Type: Article
Additional Information: Bruni, C; Buch, MH; Djokovic, A; De Luca, G; Dumitru, RB; Giollo, A; Galetti, I; Steelandt, A; Bratis, K; Suliman, YA; et al., Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment, Journal of Scleroderma and Related Disorders (Volume 8, Issue 3) pp. 169 - 182. Copyright © 2023 (The Author(s)). DOI: 10.1177/23971983231163413
Keywords: Systemic sclerosis, cardiac involvement, consensus guidance, diagnosis, follow-up, screening, Systemic sclerosis, cardiac involvement, consensus guidance, screening, diagnosis, follow-up
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: J Scleroderma Relat Disord
ISSN: 2397-1991
Language: eng
Dates:
DateEvent
October 2023Published
3 April 2023Published Online
24 February 2023Accepted
Publisher License: Publisher's own licence
Projects:
Project IDFunderFunder ID
UNSPECIFIEDWorld Scleroderma Foundationhttp://dx.doi.org/10.13039/501100023833
UNSPECIFIEDHeart Failure Association of the European Society of CardiologyUNSPECIFIED
UNSPECIFIEDItalian Ministry of University and ResearchUNSPECIFIED
PubMed ID: 37744047
Web of Science ID: WOS:000962346300001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115858
Publisher's version: https://doi.org/10.1177/23971983231163413

Actions (login required)

Edit Item Edit Item